Skip to main content

Table 1 Clinical features of analyzed patients

From: Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysis

Clinical features

Specification

All

LTS (n = 91)

STS-1 (n = 91)

LTS (subgroup, n = 80)

STS-2 (n = 80)

KPS

Median

(range)

80

(30–100)

80

(30–100)

80

(40–100)

70

(30–100)

80

(30–100)

Age

Median

(range)

55

(11–84)

54

(22–77)

56

(11–84)

56

(22–77)

55.5

(15–77)

Gender (%)

Female

42.7

45.1

52.7

42.5

28.8

 

Male

57.3

54.9

47.3

57.5

71.3

Surgery/biopsy (%)

Surgery

94.7

94.5

94.5

95.0

95.0

 

Biopsy

5.3

5.5

5.5

5.0

5.0

Dose

Median

(range)

60

(7–68)

60

(37.5–60)

60

(16–68)

60

(37.5–60)

60

(7–62)

Multifocal* (%)

Yes

65.1

50.0

81.3

50.0

66.7

 

No

34.9

50.0

18.8

50.0

33.3

  1. * Results refer to patients in whom CT scans were available